雷珠单抗用于年龄相关性黄斑变性 - Suppr

Suppr

超能文献

Ranibizumab for age-related macular degeneration.

作者信息

Cheng Jin-Wei, Wei Rui-Li

出版信息

N Engl J Med. 2011 Feb 10;364(6):582. doi: 10.1056/NEJMc1013316.

DOI:10.1056/NEJMc1013316

PMID:21306263

Abstract

摘要

相似文献

Ranibizumab for age-related macular degeneration.雷珠单抗用于年龄相关性黄斑变性

N Engl J Med. 2011 Feb 10;364(6):582. doi: 10.1056/NEJMc1013316.

Ranibizumab for age-related macular degeneration.雷珠单抗用于治疗年龄相关性黄斑变性。

N Engl J Med. 2011 Feb 10;364(6):581-2. doi: 10.1056/NEJMc1013316.

Ranibizumab therapy for neovascular age-related macular degeneration.雷珠单抗治疗新生血管性年龄相关性黄斑变性

N Engl J Med. 2010 Oct 21;363(17):1648-55. doi: 10.1056/NEJMct1000495.

Randomized study of bevacizumab vs ranibizumab for age-related macular degeneration: inappropriate conclusions.贝伐单抗与雷珠单抗治疗年龄相关性黄斑变性的随机研究：不恰当的结论。

Am J Ophthalmol. 2010 May;149(5):867; author reply 867. doi: 10.1016/j.ajo.2009.12.039.

Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration.贝伐单抗和雷珠单抗治疗新生血管性年龄相关性黄斑变性的眼部和全身安全性。

Curr Opin Ophthalmol. 2013 May;24(3):205-12. doi: 10.1097/ICU.0b013e32835f8ec0.

Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial.贝伐单抗与雷珠单抗治疗年龄相关性黄斑变性：一项前瞻性双盲随机临床试验的早期结果

Am J Ophthalmol. 2010 Aug;150(2):287; author reply 287. doi: 10.1016/j.ajo.2010.04.006.

[Non-response and change of anti-VEGF agent in exsudative age-related macular degeneration].

Klin Monbl Augenheilkd. 2010 Aug;227(8):657-8. doi: 10.1055/s-0029-1245165. Epub 2010 Aug 12.

Am J Ophthalmol. 2009 Dec;148(6):875-82.e1. doi: 10.1016/j.ajo.2009.07.009. Epub 2009 Oct 2.

Lessons learnt inform our approach to new antivascular endothelial growth factor treatments for neovascular age-related macular degeneration.所汲取的经验教训为我们采用新的抗血管内皮生长因子疗法治疗新生血管性年龄相关性黄斑变性提供了指导。

Clin Exp Ophthalmol. 2013 Nov;41(8):723-6. doi: 10.1111/ceo.12212.

The effect of image quality on retinal nerve fiber layer measurement in Stratus OCT.

Am J Ophthalmol. 2011 Feb;151(2):384; author reply 384-5. doi: 10.1016/j.ajo.2010.10.012.

引用本文的文献

A Large Outbreak of Fulminant Bacterial Endophthalmitis after Intravitreal Injection of Counterfeit Bevacizumab.玻璃体内注射假冒贝伐单抗后暴发性细菌性眼内炎的大规模暴发

Graefes Arch Clin Exp Ophthalmol. 2016 Sep;254(9):1851-6. doi: 10.1007/s00417-016-3426-7. Epub 2016 Jul 4.

Intravitreal administration of bevacizumab: pros and cons.玻璃体腔内注射贝伐单抗：利弊

Daru. 2015 Apr 21;23(1):27. doi: 10.1186/s40199-015-0110-0.

Growth of Scytalidium sp. in a counterfeit bevacizumab bottle.斯克里达尔氏菌在假冒贝伐珠单抗瓶中的生长。

Indian J Ophthalmol. 2013 Sep;61(9):523-5. doi: 10.4103/0301-4738.119455.

An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.玻璃体内注射贝伐单抗后发生内源性链球菌眼内炎。

Am J Ophthalmol. 2012 Feb;153(2):204-208.e1. doi: 10.1016/j.ajo.2011.11.035.

Lasting controversy on ranibizumab and bevacizumab.雷珠单抗和贝伐单抗的持久争议。

Theranostics. 2011;1:395-402. doi: 10.7150/thno/v01p0395. Epub 2011 Dec 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验